Lipoprotein(a): from Causality to Treatment
Current Atherosclerosis Reports – This paper reviews the evidence why lipoprotein(a) (Lp(a)) is a causal risk factor for cardiovascular disease and how high Lp(a) concentrations should be managed…
Current Atherosclerosis Reports – This paper reviews the evidence why lipoprotein(a) (Lp(a)) is a causal risk factor for cardiovascular disease and how high Lp(a) concentrations should be managed…
AbstractBackground. A comparison of diagnostic performance comparing AI-QCTISCHEMIA, CT-FFR, and physician visual interpretation on the prediction of invas
Información sobre la presentación de comunicaciones libres para el Congreso SEC 2021
MD, FHRS Consultant Cardiac Electrophysiologist Chairman, London Ventricular Tachyarrhythmia Symposium
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is), while developed as antihyperglycaemic me…
Dive into the forefront of cardiology research with our exclusive interview from the SCAI 24 Scientific Session!In this video we have Dr Mustafa Turkmani wit…
Dr Paddy Barrett, Preventive Cardiologist. Understand, assess and reduce your risk of heart disease.
Dr Paddy Barrett, Preventive Cardiologist. Understand, assess and reduce your risk of heart disease.
Correspondence to: Bengt Zöller, MD, PhD, Center for Primary Health Care Research, Skåne University Hospital, CRC, Bldg 28, Floor 11, Jan Waldenströms gata 35, S-205…